FUROSEMIDE ABSORPTION ALTERED IN DECOMPENSATED CONGESTIVE HEART-FAILURE

被引:166
作者
VASKO, MR
BROWNCARTWRIGHT, D
KNOCHEL, JP
NIXON, JV
BRATER, DC
机构
[1] VET ADM MED CTR, INTERNAL MED SERV, DALLAS, TX 75216 USA
[2] UNIV TEXAS, HLTH SCI CTR, SW MED SCH, DEPT PHARMACOL, DALLAS, TX 75235 USA
[3] UNIV TEXAS, HLTH SCI CTR, SW MED SCH, DEPT INTERNAL MED, DALLAS, TX 75235 USA
关键词
D O I
10.7326/0003-4819-102-3-314
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:314 / 318
页数:5
相关论文
共 17 条
[1]  
BENET LZ, 1976, EFFECT DISEASE STATE, P33
[2]   PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE [J].
BENOWITZ, NL ;
MEISTER, W .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :389-405
[3]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[4]   ABSORPTION AND DISPOSITION OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE [J].
BRATER, DC ;
SEIWELL, R ;
ANDERSON, S ;
BURDETTE, A ;
DEHMER, GJ ;
CHENNAVASIN, P .
KIDNEY INTERNATIONAL, 1982, 22 (02) :171-176
[5]   FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].
BRATER, DC ;
CHENNAVASIN, P ;
SEIWELL, R ;
BECK, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186
[6]   RESISTANCE TO DIURETICS - EMPHASIS ON A PHARMACOLOGICAL PERSPECTIVE [J].
BRATER, DC .
DRUGS, 1981, 22 (06) :477-494
[7]   BUMETANIDE AND FUROSEMIDE IN HEART-FAILURE [J].
BRATER, DC ;
DAY, B ;
BURDETTE, A ;
ANDERSON, S .
KIDNEY INTERNATIONAL, 1984, 26 (02) :183-189
[8]   PHARMACODYNAMIC ANALYSIS OF THE FUROSEMIDE-PROBENECID INTERACTION IN MAN [J].
CHENNAVASIN, P ;
SEIWELL, R ;
BRATER, DC ;
LIANG, WMM .
KIDNEY INTERNATIONAL, 1979, 16 (02) :187-195
[9]  
CRAIG RM, 1983, J LAB CLIN MED, V101, P496
[10]  
GIBALDI M, 1975, PHARMACOKINETICS